Treatment of infections caused by carbapenemase-producing Enterobacterales

Antibiotic resistance is one of the main menaces to public and individual health worldwide. In the last two decades,
an increase in the detection of carbapenem-resistant Enterobacterales has been reported. The treatment of infections caused by these strains is a therapeutic challenge. The use of carbapenems may be beneficial depending on MIC value and source of infection. New drugs, with different activity against the different classes of carbapenemases, are developed showing significant benefits.